Award recordCONTRACT

IMMUCOR INC

PIID 36C25719N0060· VHA· 257-NETWORK CONTRACT OFFICE 17 (36C257)· Q301 · MEDICAL- LABORATORY TESTING· FY2019· $169,187 net obligations· UEI KV8AGJX7NMZ7· GA

Description

IMMUCOR BLOOD BANK REAGENTS - DE-OBLIGATE EXCESS FUNDS

Base award description: IGF::OT::IGF IMMUCOR BLOOD BANK REAGENTS

First action · last action
2018-10-01 · 2024-02-14
Transactions
12
First transaction's obligation
$28,275
Base + all options value (sum of deltas)
$197,556
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
—
Offers received
2
SDVOSB flag on record
No
Parent IDV
V797D70110
NAICS
325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING

Modification chain · 12 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$169,467$0Base award · 2018-10-01 · this action $28,275 · running total $28,275Modification P00001 · 2019-09-18 · this action $0 · running total $28,275Modification P00002 · 2019-10-01 · this action $28,182 · running total $56,458Modification P00003 · 2020-09-29 · this action $0 · running total $56,458Modification P00005 · 2020-10-01 · this action $28,275 · running total $84,733Modification P00006 · 2021-07-16 · this action $28,275 · running total $113,009Modification P00007 · 2021-10-01 · this action $28,275 · running total $141,284Modification P00008 · 2022-05-13 · this action -$93 · running total $141,191Modification P00010 · 2022-08-31 · this action $0 · running total $141,191Modification P00014 · 2022-10-01 · this action $28,275 · running total $169,467Modification P00015 · 2022-10-14 · this action $0 · running total $169,467Modification P00018 · 2024-02-14 · this action -$280 · running total $169,187
  • Base2018-10-01+$28,275= $28,275
  • Mod P000012019-09-18+$0= $28,275
  • Mod P000022019-10-01+$28,182= $56,458
  • Mod P000032020-09-29+$0= $56,458
  • Mod P000052020-10-01+$28,275= $84,733
  • Mod P000062021-07-16+$28,275= $113,009
  • Mod P000072021-10-01+$28,275= $141,284
  • Mod P000082022-05-13-$93= $141,191
  • Mod P000102022-08-31+$0= $141,191
  • Mod P000142022-10-01+$28,275= $169,467
  • Mod P000152022-10-14+$0= $169,467
  • Mod P000182024-02-14-$280= $169,187
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2018-10-01+$28,275$28,275IGF::OT::IGF IMMUCOR BLOOD BANK REAGENTS
Mod P00001· EXERCISE AN OPTION2019-09-18+$0$28,275IMMUCOR BLOOD BANK REAGENTS
Mod P00002· EXERCISE AN OPTION2019-10-01+$28,182$56,458IMMUCOR BLOOD BANK REAGENTS
Mod P00003· EXERCISE AN OPTION2020-09-29+$0$56,458IMMUCOR BLOOD BANK REAGENTS
Mod P00005· EXERCISE AN OPTION2020-10-01+$28,275$84,733IMMUCOR BLOOD BANK REAGENTS
Mod P00006· EXERCISE AN OPTION2021-07-16+$28,275$113,009IMMUCOR BLOOD BANK REAGENTS
Mod P00007· FUNDING ONLY ACTION2021-10-01+$28,275$141,284IMMUCOR BLOOD BANK REAGENTS
Mod P00008· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2022-05-13−$93$141,191IMMUCOR BLOOD BANK REAGENTS
Mod P00010· EXERCISE AN OPTION2022-08-31+$0$141,191IMMUCOR BLOOD BANK REAGENTS
Mod P00014· EXERCISE AN OPTION2022-10-01+$28,275$169,467IMMUCOR BLOOD BANK REAGENTS
Mod P00015· OTHER ADMINISTRATIVE ACTION2022-10-14+$0$169,467IMMUCOR BLOOD BANK REAGENTS
Mod P00018· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2024-02-14−$280$169,187IMMUCOR BLOOD BANK REAGENTS - DE-OBLIGATE EXCESS FUNDS

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI KV8AGJX7NMZ7)

AwardOffice · PSC / listingNet obligationsFY
36C24526F0359245-NETWORK CONTRACT OFFICE 5 (36C245) · 6640 · LABORATORY EQUIPMENT AND SUPPLIES$65,480FY2026
36C24526F0345245-NETWORK CONTRACT OFFICE 5 (36C245) · 6640 · LABORATORY EQUIPMENT AND SUPPLIES$65,480FY2026
36C24926N0126249-NETWORK CONTRACT OFFICE 9 (36C249) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS$37,477FY2026
36C24725F0271247-NETWORK CONTRACT OFFICE 7 (36C247) · H266 · EQUIPMENT AND MATERIALS TESTING- INSTRUMENTS AND LABORATORY EQUIPMENT$158,618FY2025
36C25025F0706250-NETWORK CONTRACT OFFICE 10 (36C250) · 6640 · LABORATORY EQUIPMENT AND SUPPLIES$201,180FY2025
36C25025F0696250-NETWORK CONTRACT OFFICE 10 (36C250) · 6640 · LABORATORY EQUIPMENT AND SUPPLIES$66,971FY2025

Other recipients under Q301 from 257-NETWORK CONTRACT OFFICE 17 (36C257) (most recent first)

AwardRecipientOfficeNet obligationsFY
36C25726N0415UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO257-NETWORK CONTRACT OFFICE 17 (36C257)$27,000FY2026
36C25726N0419EXACT SCIENCES CORPORATION257-NETWORK CONTRACT OFFICE 17 (36C257)$127,174FY2026
36C25726N0422PROPATH SERVICES, LLC257-NETWORK CONTRACT OFFICE 17 (36C257)$1,531,914FY2026
36C25726N0390NEOGENOMICS LABORATORIES, INC.257-NETWORK CONTRACT OFFICE 17 (36C257)$493,650FY2026
36C25726N0382BIODESIX, INC257-NETWORK CONTRACT OFFICE 17 (36C257)$40,696FY2026

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C25719N0060_3600_V797D70110_3600 · retrieved 2026-09-26.